Analystreport

Iradimed Corporation (NASDAQ: IRMD) had its "buy" rating re-affirmed by analysts at Roth Capital.

iRadimed Corporation  (IRMD) 
Last iradimed corporation earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: iradimed.com/en-us/investors/investor-contact